No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA —According to recent reports by Reuters, Pfizer, a US-based pharmaceutical company, has developed a vaccine for respiratory syncytial virus (RSV) and is prepared to launch it pending regulatory approval.…
Read More
UNITED KINGDOM — Pharmaceutical giant GlaxoSmithKline (GSK) has been revealed as the top-performing FTSE 100 business on gender equality, according to a new index, The Independent has reported. The Equity…
Read More
UNITED KINGDOM — The U.S. FDA has approved GlaxoSmithKline’s (GSK) Jesduvroq (daprodustat) for the treatment of anemia caused by chronic kidney disease (CKD) in adults who have been on dialysis…
Read More
UNITED KINGDOM —GSK has posted robust quarterly earnings that beat expectations on the back of sales of its shingles vaccine and said it was upbeat this year despite a decline…
Read More
UAE – Pharmaceutical giant GSK plc, formerly GlaxoSmithKline plc., with support from Dubai-based pulmonologists and global experts has unveiled its advanced training programme on the management of respiratory diseases dubbed…
Read More
CHINA – WuXi Biologics, a leading global open-access biologics technology platform, has signed an exclusive global licensing agreement worth up to US$1.46 billion with pharmaceutical giant GSK plc, formerly GlaxoSmithKline…
Read More
UAE – GlaxoSmithKline (GSK) and Aster DM Healthcare, a private healthcare service provider, have announced an expansion of their strategic medical partnership to promote healthy ageing in the United Arab…
Read More
SINGAPORE — GSK, Sanofi, and Takeda are set to collaborate with researchers from the Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS), Nanyang Technological University, Singapore…
Read More
NIGERIA – Save the Children International Nigeria (SCI), through the INSPIRING Project, has donated the District Health Information Software 2 (DHIS2) Dashboard App, and 30 internet tablets to the Lagos…
Read More
USA — British pharma giant GSK is set to withdraw its blood cancer drug Blenrep from the U.S. market, following a request from the Food and Drug Administration. Blenrep belongs…
Read More